- Home
- EVRI vs CGON Comparison
EVRI vs CGON Comparison
Compare EVRI & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- CGON
- Stock Information
- Founded
- EVRI 1998
- CGON 2010
- Country
- EVRI United States
- CGON United States
- Employees
- EVRI N/A
- CGON N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- CGON
- Sector
- EVRI Consumer Discretionary
- CGON
- Exchange
- EVRI Nasdaq
- CGON NYSE
- Market Cap
- EVRI 1.2B
- CGON 1.3B
- IPO Year
- EVRI 2005
- CGON 2024
- Fundamental
- Price
- EVRI $14.05
- CGON $23.74
- Analyst Decision
- EVRI Hold
- CGON Strong Buy
- Analyst Count
- EVRI 4
- CGON 11
- Target Price
- EVRI $12.83
- CGON $62.90
- AVG Volume (30 Days)
- EVRI 1.7M
- CGON 2.1M
- Earning Date
- EVRI 05-20-2025
- CGON 05-20-2025
- Dividend Yield
- EVRI N/A
- CGON N/A
- EPS Growth
- EVRI N/A
- CGON N/A
- EPS
- EVRI 0.17
- CGON N/A
- Revenue
- EVRI $757,903,000.00
- CGON $1,139,000.00
- Revenue This Year
- EVRI $1.83
- CGON N/A
- Revenue Next Year
- EVRI $3.48
- CGON $16,237.24
- P/E Ratio
- EVRI $82.71
- CGON N/A
- Revenue Growth
- EVRI N/A
- CGON 461.08
- 52 Week Low
- EVRI $6.37
- CGON $14.80
- 52 Week High
- EVRI $14.06
- CGON $40.47
- Technical
- Relative Strength Index (RSI)
- EVRI 69.71
- CGON 49.91
- Support Level
- EVRI $13.72
- CGON $21.00
- Resistance Level
- EVRI $14.06
- CGON $30.23
- Average True Range (ATR)
- EVRI 0.05
- CGON 2.33
- MACD
- EVRI 0.01
- CGON 0.06
- Stochastic Oscillator
- EVRI 96.87
- CGON 30.94
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.